FDAnews
www.fdanews.com/articles/196208-dianosic-grabs-ce-mark-for-intranasal-bleeding-treatment

Dianosic Grabs CE Mark for Intranasal Bleeding Treatment

March 11, 2020

Dianosic’s CAVI-T device has received CE Mark certification for treatment of spontaneous and post-operative intranasal bleeding.

The low-pressure asymmetric balloon applies compression at low force to stop bleeding while adapting to the anatomy of the nasal fossa, one of the two nasal cavities.

The intranasal balloon can stay in place for up to three days and is designed for use in hospitals, the company said.

View today's stories